This protocol covers lead poisoning in the specific clinical setting where seizures are present, a situation that calls for targeted anticonvulsant management as part of the overall approach.
Seizures are the defining comorbidity in this sub-population. Their presence shapes the acute management priorities, and initial anticonvulsant therapy — including intravenous options — is a key component of care.
When seizures persist or recur, the protocol calls for a specific additional anticonvulsant agent. The full regimen — including agent selection, appropriate dosing by patient group, and clinical sequencing — is detailed in the structured protocol below.
Seizures may be treated with intravenous benzodiazepine.
If seizures recur after diazepam, consider phenobarbital (30 mg adults; 10 mg children >5 years old).
View source ↗